4.7 Article

Dopamine-3 receptor modulates intraocular pressure: Implications for glaucoma

Journal

BIOCHEMICAL PHARMACOLOGY
Volume 83, Issue 5, Pages 680-686

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2011.11.031

Keywords

Dopamine-(3) receptor; Intraocular pressure; Optic neuropathy; Glaucoma

Funding

  1. National grant [PON01-00110]

Ask authors/readers for more resources

The aim of the present study was to investigate the role of D-3 receptor on intraocular pressure regulation using WT and KO D3R-/- mice. Both mice were used with normal eye pressure or steroid-induced ocular hypertension. As measured by tonometry, the topical application of 7-OH-DPAT, a dopamine D-3-preferring receptor agonist, significantly decreased, in a dose-dependent manner, the intraocular pressure in WT mice both in an ocular normotensive group and an ocular hypertensive group. Pretreatment with U-99194A, a D-3 receptor antagonist. reverted 7-OH-DPAT induced ocular hypotension in VVT mice. No change of intraocular pressure was observed after topical application of 7-OH-DPAT in KO D3R-/- mice. PCR analysis demonstrated the presence of all dopamine receptor genes in eye tissues obtained from WT mice, and the lack of D3R mRNAs in KO mice. The present study identified the D3R subtype as the most important receptor of the dopaminergic system to modulate intraocular pressure with relevant implications for glaucoma that represents one of the most crippling optic neuropathies. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available